High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D016572:Cyclosporine / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000178:diet therapy / Q000188:drug therapy / Q000453:epidemiology*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D007328:Insulin / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D011239:Prednisolone / Q000627:therapeutic use*; D012189:Retrospective Studies; D012307:Risk Factors
D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D007328:Insulin; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine